These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21432752)

  • 21. [Clinical observations with aripiprazole in schizophrenia].
    Gaszner P
    Neuropsychopharmacol Hung; 2006 Mar; 8(1):29-32. PubMed ID: 16841563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trial of aripiprazole in the treatment of first-episode schizophrenia.
    Lee HY; Ham BJ; Kang RH; Paik JW; Hahn SW; Lee MS; Lee MS
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):38-43. PubMed ID: 20416024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aripiprazole for the treatment of schizophrenia with co-occurring social anxiety: an open-label cross-taper study.
    Stern RG; Petti TA; Bopp K; Tobia A
    J Clin Psychopharmacol; 2009 Jun; 29(3):206-9. PubMed ID: 19440071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Bae KY; Yang SJ; Yoon JS
    Clin Neuropharmacol; 2010 May; 33(3):121-5. PubMed ID: 20502130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of psychotic disorders with aripiprazole in the emergency psychiatric setting.
    Raja M; Azzoni A
    Psychiatr Danub; 2008 Sep; 20(3):323-8. PubMed ID: 18827757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of aripiprazole versus risperidone for the treatment of amphetamine-induced psychosis.
    Farnia V; Shakeri J; Tatari F; Juibari TA; Yazdchi K; Bajoghli H; Brand S; Abdoli N; Aghaei A
    Am J Drug Alcohol Abuse; 2014 Jan; 40(1):10-5. PubMed ID: 24359506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients.
    Takekita Y; Kato M; Wakeno M; Sakai S; Suwa A; Nishida K; Okugawa G; Kinoshita T
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():110-4. PubMed ID: 23022672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism.
    Naber D; Lambert M
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1213-9. PubMed ID: 15588748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the DRD3 Ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors.
    Chen SF; Shen YC; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):470-4. PubMed ID: 19302829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switching to aripiprazole in outpatients with schizophrenia experiencing insufficient efficacy and/or safety/tolerability issues with risperidone: a randomized, multicentre, open-label study.
    Ryckmans V; Kahn JP; Modell S; Werner C; McQuade RD; Kerselaers W; Lissens J; Sanchez R
    Pharmacopsychiatry; 2009 May; 42(3):114-21. PubMed ID: 19452380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with schizophrenia treated with aripiprazole, a multicentre naturalistic study.
    Christensen AF; Poulsen J; Nielsen CT; Bork B; Christensen A; Christensen M
    Acta Psychiatr Scand; 2006 Feb; 113(2):148-53. PubMed ID: 16423167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent hiccups associated with switching from risperidone to aripiprazole in a schizophrenic patient with cerebral palsy.
    Yeh YW
    Clin Neuropharmacol; 2011; 34(4):135-6. PubMed ID: 21768798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aripiprazole: new drug. Just another neuroleptic.
    Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA).
    Wolf J; Janssen F; Lublin H; Salokangas RK; Allain H; Smeraldi E; Bernardo M; Millar H; Pans M; Adelbrecht C; Laughton J; Werner C; Maier W
    Curr Med Res Opin; 2007 Oct; 23(10):2313-23. PubMed ID: 17706003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement in social competence in patients with schizophrenia: a pilot study using a performance-based measure using virtual reality.
    Park KM; Ku J; Park IH; Park JY; Kim SI; Kim JJ
    Hum Psychopharmacol; 2009 Dec; 24(8):619-27. PubMed ID: 19946937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
    Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ;
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined use of ECT with aripiprazole.
    Lopez-Garcia P; Chiclana C; Gonzalez R
    World J Biol Psychiatry; 2009; 10(4 Pt 3):942-3. PubMed ID: 17853257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subjective, cognitive/psychomotor, and physiological effects of aripiprazole in Chinese light and heavy smokers.
    Liu Y; Sun HQ; Bao YP; Li SX; Beveridge TJ; Di XL; Yang FD; Lu L
    Drug Alcohol Depend; 2009 Apr; 101(1-2):42-52. PubMed ID: 19070440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia.
    Yasui-Furukori N; Furukori H; Sugawara N; Fujii A; Kaneko S
    J Clin Psychopharmacol; 2010 Oct; 30(5):596-9. PubMed ID: 20814333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for the partial dopamine-receptor agonist aripiprazole as a first-line treatment of psychosis in patients with iatrogenic or tumorogenic hyperprolactinemia.
    Hoffer ZS; Roth RL; Mathews M
    Psychosomatics; 2009; 50(4):317-24. PubMed ID: 19687170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.